Privia Health Group PRVA
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Privia Health Group (PRVA) Core Market Data and Business Metrics
Latest Closing Price
$22.36Price-Earnings Ratio
372.67Total Outstanding Shares
120.51 Million SharesDividend
No dividendSIC Description
Services-health ServicesPrimary Exchange
NASDAQHeadquarters
950 N. Glebe Rd., Suite 700, Arlington, VA, 22203
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 939,412 Shares | 4.71 | 3/14/2025 | 4,427,103 Shares |
| 999,157 Shares | 4.15 | 2/28/2025 | 4,143,718 Shares |
| 566,764 Shares | 8.23 | 2/14/2025 | 4,662,649 Shares |
| 570,674 Shares | 8.62 | 1/31/2025 | 4,919,187 Shares |
| 598,119 Shares | 9.58 | 1/15/2025 | 5,731,455 Shares |
| 679,689 Shares | 8.5 | 12/31/2024 | 5,774,753 Shares |
Cash Flow Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $1.49 Million |
| Net Cash Flow | $34.65 Million |
| Net Cash Flow From Financing Activities, Continuing | $1.49 Million |
| Net Cash Flow From Operating Activities | $33.15 Million |
| Net Cash Flow From Operating Activities, Continuing | $33.15 Million |
| Net Cash Flow From Investing Activities | $0 |
Income Statement
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Costs And Expenses | $429.94 Million |
| Income/Loss From Continuing Operations After Tax | $3.98 Million |
| Diluted Average Shares | $125.75 Million |
| Basic Average Shares | $119.66 Million |
| Net Income/Loss | $3.98 Million |
| Nonoperating Income/Loss | $2.16 Million |
Comprehensive Income
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $3.98 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $3.98 Million |
| Other Comprehensive Income/Loss | $0 |
Balance Sheet
July 1, 2024 to September 30, 2024
| Metric | Value |
|---|---|
| Equity | $662.18 Million |
| Liabilities And Equity | $1.15 Billion |
| Equity Attributable To Noncontrolling Interest | $47.30 Million |
| Noncurrent Liabilities | $3.91 Million |
| Noncurrent Assets | $291.81 Million |
| Assets | $1.15 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||